Ch+10+Host+mirobe+interaction

Host-Microbe Interactions

Overview

  • Host-microbe interactions can be harmless or pathogenic.

  • Dysbiosis: A state of microbiota disruption can cause disease.

    • Example: Antibiotic use can kill normal gut microbiota, allowing pathogens like Clostridium difficile to flourish.

Clinical Implications of Dysbiosis

  • Normal Microbiota: Present in healthy individuals; protects against pathogenic colonization.

  • Antibiotic Therapy: Used for infections (e.g., pneumonia) can disrupt gut flora.

  • C. difficile Exposure: Can be through contaminated surfaces or healthcare workers; exposure can lead to opportunistic infections due to reduced competition.

Virulence Factors and Pathogenicity

Definitions

  • Pathogenicity: The capacity of a microbe to cause disease.

  • Virulence: The degree of disease caused by a pathogen.

  • Virulence Factors: Attributes that enable microbes to breach host defenses (e.g., adhesion, invasion).

Mechanisms of Damage

  • Virulence Factors can:

    • Directly damage host cells.

    • Trigger severe immune responses, leading to tissue damage.

Pathogen Characteristics

Pathogen Virulence

  • Not all pathogens share the same virulence levels; some can persist in a host or community without causing immediate illness.

    • Pathogens causing outbreaks typically have high mortality but are short-lived and geographically labeled.

Infectious Dose and Lethal Dose

  • Infectious Dose (ID50): Number of microorganisms required to infect 50% of hosts. Lower ID50 indicates higher infectiousness.

  • Lethal Dose (LD50): Amount of a toxin required to kill 50% of hosts. This is crucial for understanding disease severity but influenced by:

    • Host species

    • Immune status

    • Entry route.

Toxins as Virulence Factors

Toxins Overview

  • Toxins: Molecules damaging host tissues and hindering immune responses. Two classes:

    • Endotoxins: Lipid components of Gram-negative bacteria (e.g., Lipopolysaccharide - LPS).

    • Exotoxins: Soluble proteins from various bacteria, more toxic than endotoxins.

Key Differences between Endotoxins and Exotoxins

  • Endotoxins: Made of lipids, released upon bacterial death, induce fever, and cannot be neutralized easily.

  • Exotoxins: Made of proteins, secreted by living bacteria, can be neutralized, and often have higher toxicity levels.

Mechanisms of Action for Toxins

Endotoxin Effects

  • Majorly released when Gram-negative bacteria die, causing systemic responses like fever and shock if levels are high enough.

Exotoxin Families

  • Type I: Affect cell surfaces without entering the cell.

  • Type II: Damage host cell membranes, causing lysis.

  • Type III: Intracellular toxins entering host cells to exert effects (e.g., inhibit protein synthesis). Examples include Diphtheria toxin and Cholera toxin.

Steps to Pathogenic Infection

Five Steps to Infection

  1. Entry into Host: Via mucous membranes.

  2. Adhesion: Initial nonspecific adhesion, followed by specific binding via adhesins.

  3. Invasion: Pathogens can remain at the surface, invade deeper, or reside intracellularly.

  4. Replication & Evasion: Must replicate while evading the immune response.

  5. Transmission: Symptoms may aid in transmission (e.g., sneezing, diarrhea).

Immune Evasion Strategies

Evading the Immune System

  • Pathogens develop mechanisms to hide from or undermine immune responses, including:

    • Intracellular survival.

    • Antigen mimicry or variation.

    • Suppressing immune function or causing immune cell apoptosis.

Key Mechanisms

  • Interference with Phagocytosis: By mechanisms such as capsule formation or production of enzymes targeting immune cells.

  • Immune Suppression: Directly targeting immune cells or producing proteases to degrade antibodies.

Transmission and Exit Strategies

Exiting the Host

  • Pathogens typically exit through similar portals they use to enter (e.g., respiratory droplets, bodily fluids).

  • Reservoirs can be environmental niches or infected hosts (e.g., fomite transmission).

Infection Control in Healthcare

Biosafety Levels

  • BSL-1: Minimal threat to healthy individuals.

  • BSL-2: Agents can cause disease; not airborne, managed with standard precautions.

  • BSL-3: Serious diseases with airborne risk; high severity.

  • BSL-4: Lethal pathogens without treatments available.

Universal and Standard Precautions

  • Implement practices to minimize transmission of blood-borne pathogens, including:

    • Hand hygiene.

    • Use of personal protective equipment.

    • Proper waste disposal.

Transmission Precautions

  • Contact, droplet, and airborne precautions tailored to specific infectious agents to limit spread in healthcare settings.